基础医学与临床 ›› 2014, Vol. 34 ›› Issue (7): 1010-1013.

• 短篇综述 • 上一篇    下一篇

慢性阻塞性肺病Sirtuins的研究进展

陈刚   

  1. 解放军第四二五医院
  • 收稿日期:2013-08-14 修回日期:2013-12-21 出版日期:2014-07-05 发布日期:2014-06-24
  • 通讯作者: 陈刚 E-mail:13278979790@163.com

Recent advances of Sirtuins in chronic obstructive pulmonary disease

  • Received:2013-08-14 Revised:2013-12-21 Online:2014-07-05 Published:2014-06-24

摘要: Sirtuins是第III类组蛋白去乙酰化酶,主要成员SIRT1、SIRT6与慢性阻塞性肺疾病(COPD)发病机制有密切关系。SIRT1、SIRT6在COPD患者肺部中表达下调,并通过多种机制调节炎性反应、肺部自噬与衰老。Sirtuins可能是COPD发生过程中的一个调控分子家族。

关键词: 慢性阻塞性肺病, Sirtuins, SIRT1, SIRT6

Abstract: Sirtuins are class III histone deacetylase. SIRT1 and SIRT6 are the major members of Sirtuins participated in the development of chronic obstructive pulmonary disease(COPD). The expression of SIRT1 and SIRT6 were down-regulated in the lungs of patients with COPD, and they regulate inflammatory reaction, lung autophagy and senescence through multiple mechanisms. Sirtuins may be one of main regulatory molecules family in the progression of COPD.

Key words: COPD, Sirtuins, SIRT1, SIRT6